<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
10829-0025-1
</NDCCode>
<PackageDescription>
60 BOTTLE in 1 CASE (10829-0025-1) / 30 TABLET, FILM COATED in 1 BOTTLE (10829-0025-3)
</PackageDescription>
<NDC11Code>
10829-0025-01
</NDC11Code>
<ProductNDC>
10829-0025
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Orforglipron
</NonProprietaryName>
<DosageFormName>
TABLET, FILM COATED
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20260521
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Pfizer Italia S.r.l.
</LabelerName>
<SubstanceName>
ORFORGLIPRON CALCIUM
</SubstanceName>
<StrengthNumber>
2.5
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2026-05-22
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
21-MAY-26
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>